pei.de
German federal institute regulating vaccines and biomedicines and conducting research on their safety and efficacy
About pei.de
The Paul-Ehrlich-Institut is Germany’s federal institute for vaccines and biomedical medicinal products. It assesses their benefit-risk profiles, oversees quality, efficacy and safety, and conducts research on basic and regulatory science.
The institute works with national and international life-sciences organizations and advises on medicinal product development. Its staff includes scientists from fields such as medicine, biology, chemistry, biotechnology and bioinformatics.
Product: Regulatory assessment, surveillance and research concerning vaccines and biomedical medicinal products.
Jobs at pei.de
More govtech & civic companies
peoplecheck.de
Search portal for German commercial and association register entries, business addresses and insolvency noticesNew on Evolcpi-muenchen.de
Munich city education institute offering continuing education and advisory services for childcare and school educatorsNew on Evolcpolizei-beratung.de
Police crime-prevention programme offering free advice on scams, burglary, cybercrime and victim rights to citizens across Germanypotsdam.de
Municipal administration and public services for residents, businesses and visitors in Potsdam, Germanyppa-duew.de
Public-sector administration services for municipalities and employers in Rhineland-PalatinateNew on Evolcprosoz.de
Municipal software and consulting for building, social, youth and public-order authorities in GermanyNew on EvolcRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.